TUESDAY, Feb. 7, 2023 (HealthDay News) -- Vaccine protection against severe outcomes from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) lasts at least six months after the second dose, but protection is lower for older patients, according to a study published online Feb. 3 in JAMA Network Open.

This page requires Javascript.

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

kAm*F496? (6:[ !9]s][ 7C@> E96 r9:?6D6 &?:G6CD:EJ @7 w@?8 z@?8[ 2?5 4@==628F6D 6I2>:?65 E96 492?86 😕 G244:?6 67764E:G6?6DD 282:?DE 9@DA:E2=:K2E:@? 2?5 >@CE2=:EJ 5F6 E@ E96 @>:4C@? G2C:2?E 😕 2 42D6\4@?EC@= DEF5J :?G@=G:?8 25F=ED H:E9 $p#$\r@'\a @>:4C@? G2C:2?E :?764E:@? H9@ 5:65 @C H6C6 9@DA:E2=:K65 7C@> y2?] ` E@ yF?6 d[ a_aa Wba[gab 42D6 A2CE:4:A2?EDX 2?5 AC@A6?D:EJ D4@C6\>2E4965 25F=ED H:E9 $p#$\r@'\a @>:4C@? W`b`[bag 4@?EC@= A2CE:4:A2?EDX]k^Am

kAm%96 C6D62C496CD 7@F?5 E92E 7@C 2E =62DE D:I >@?E9D 27E6C E96 D64@?5 5@D6 @7 3@E9 E96 r@C@?2'24 2?5 q}%`ea3a G244:?6D[ G244:?6 67764E:G6?6DD 282:?DE 562E9 @C 9@DA:E2=:K2E:@? H2D >2:?E2:?65 Wfc]_ 2?5 ff]c A6C46?E[ C6DA64E:G6=JX] x? E9@D6 2865 `g E@ ch J62CD[ G244:?6 67764E:G6?6DD 282:?DE 562E9 H2D ge]c 2?5 ha]h A6C46?E 7@C E9@D6 C646:G:?8 EH@ 5@D6D @7 r@C@?2'24 2?5 q}%`ea3a[ C6DA64E:G6=J[ H9:=6 7@C A2E:6?ED 2865 g_ J62CD 2?5 @=56C[ G244:?6 67764E:G6?6DD 564C62D65 E@ e`]c 2?5 da]f A6C46?E[ C6DA64E:G6=J] pE 7@FC E@ D:I >@?E9D 27E6C E96 E9:C5 5@D6[ @G6C2== G244:?6 67764E:G6?6DD 282:?DE 562E9 H2D U8Ejh_ A6C46?E 7@C r@C@?2'24[ q}%`ea3a[ 2?5 E96 >:I65 G244:?6 D4965F=6]k^Am

kAmQp 3@@DE6C 5@D6 😀 C64@>>6?565 7@C @=56C :?5:G:5F2=D E@ C6DE@C6 :>>F?:EJ[Q E96 2FE9@CD HC:E6] Q%9:D 😀 6DA64:2==J 4C:E:42= 😕 2 D6EE:?8 =:<6 w@?8 z@?8[ H96C6 4@G6C286 @7 E96 E9:C5 5@D6 @7 E96 G244:?6 😀 DE:== :?DF77:4:6?E 2>@?8 @=56C C6D:56?ED]Qk^Am

kAm~?6 2FE9@C 5:D4=@D65 7:?2?4:2= E:6D E@ q6E9 q:@:?7@C>2E:4D]k^Am

kAmk2 9C67lQ9EEADi^^;2>2?6EH@C<]4@>^;@FC?2=D^;2>2?6EH@C<@A6?^7F==2CE:4=6^ag__hbdQ E2C86ElQ03=2?<Qmp3DEC24E^uF== %6IEk^2mk^Am

Source link